Acute renal failure following oral sodium phosphate bowel preparation: a nationwide case-crossover study

Background and study aims: Oral sodium phosphate (OSP) is a cleansing agent for colonoscopy. Recent reports have cited an increased risk of acute renal failure (ARF) in OSP bowel purgative users, but this risk remains under debate. This study was performed to evaluate the association between OSP and ARF in patients who underwent colonoscopy.

Patients and methods: A population-based case-crossover study was conducted using the Korean Health Insurance Review and Assessment Service (HIRA) claims data from 1 January 2005 to 31 December 2009. The study population consisted of patients aged ≥ 50 years who underwent colonoscopies after an OSP prescription prior to their first hospitalization for ARF. For each patient, one hazard and four control periods were matched at specified time windows. Conditional logistic regression analysis was used to estimate the odds ratio (OR) and 95 % confidence interval (CI), adjusting for concomitant medications that could induce ARF.

Results: A total of 1105 patients were included (54 % male). The adjusted ORs for ARF related to the use of OSP when applying the 1-, 2-, 4-, 8-, or 12-week time windows were 3.7 (95 %CI 2.37 – 5.67), 3.5 (95 %CI 2.45 – 4.89), 3.0 (95 %CI 2.30 – 3.95), 2.4 (95 %CI 1.93 – 2.96), and 2.0 (95 %CI 1.69 – 2.46), respectively. When adopting an 8-week time window, the adjusted OR was 2.5 (95 %CI 1.98 – 3.16) for the subgroup without chronic renal failure.

Conclusions: The use of OSP was significantly associated with ARF both in patients with and without co-morbidities.

^* These authors contributed equally to this work.

• References

• 1 Occhipinti KE, Di Palma JA. How to choose the best preparation for colonoscopy. Nat Rev Gastroenterol Hepatol 2009; 6: 279-286
• 2 Fine A, Patterson J. Severe hyperphosphatemia following phosphate administration for bowel preparation in patients with renal failure: two cases and review of the literature. Am J Kidney Dis 1997; 29: 103-105
• 3 Orias M, Mahnensmith RL, Perazalla MA. Extreme hyperphosphatemia and acute renal failure after a phosphorus-containing bowel regimen. Am J Nephrol 1999; 19: 60-63
• 4 Ullah N, Yeh R, Ehrinpreis M. Fatal hyperphosphatemia from a phosphosoda bowel preparation. J Clin Gastroenterol 2002; 34: 457-458
• 5 Markowitz GS, Stokes MB, Radhakrishnan J et al. Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an underrecognized cause of chronic renal failure. J Am Soc Nephrol 2005; 16: 3389-3396
• 6 Hurst FP, Bohen EM, Osgard EM et al. Association of oral sodium phosphate purgative use with acute kidney injury. J Am Soc Nephrol 2007; 18: 3192-3198
• 7 Brunelli SM, Lewis JD, Gupta M et al. Risk of kidney injury following oral phosphosoda bowel preparations. J Am Soc Nephrol 2007; 18: 3199-3205
• 8 Seol DC, Hong SN, Kim JH et al. Change in renal function after sodium phosphate preparation for screening colonoscopy. World J Gastroenterol 2010; 16: 2010-2016
• 9 Russmann S, Lamerato L, Motsko SP et al. Risk of further decline in renal function after the use of oral sodium phosphate or polyethylene glycol in patients with a preexisting glomerular filtration rate below 60 ml/min. Am J Gastroenterol 2008; 103: 2707-2716
• 10 Khurana A, McLean L, Atkinson S et al. The effect of oral sodium phosphate drug products on renal function in adults undergoing bowel endoscopy. Arch Intern Med 2008; 168: 593-597
• 11 Zuccaro Jr G, Connor JT, Schreiber Jr M. Colonoscopy preparation: are our patients at risk?. Am J Gastroenterol 2007; 102: 2664-2666
• 12 Roy HK, Bianchi LK. Purging the colon while preserving the kidneys. Arch Intern Med 2008; 168: 565-567
• 13 Brunelli SM. Association between oral sodium phosphate bowel preparations and kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009; 53: 448-456
• 14 Russmann S, Lamerato L, Marfatia A et al. Risk of impaired renal function after colonoscopy: a cohort study in patients receiving either oral sodium phosphate or polyethylene glycol. Am J Gastroenterol 2007; 102: 2655-2663
• 15 Horwitz J, Vakil N. Risk of impaired renal function after colonoscopy. Am J Gastroenterol 2008; 103: 1309
• 16 Warner L, Macaluso M, Austin HD et al. Application of the case-crossover design to reduce unmeasured confounding in studies of condom effectiveness. Am J Epidemiol 2005; 161: 765-773
• 17 Maclure M, Mittleman MA. Should we use a case-crossover design?. Annu Rev Public Health 2000; 21: 193-221
• 18 Choi NK, Chang Y, Choi YK et al. Signal detection of rosuvastatin compared to other statins: data-mining study using national health insurance claims database. Pharmacoepidemiol Drug Saf 2010; 19: 238-246
• 19 World Health Organization. International classification of diseases (ICD). Available from: http://www.who.int/classifications/icd/en/ Accessed: 4 October 2012
• 20 Delaney JA, Suissa S. The case-crossover study design in pharmacoepidemiology. Stat Methods Med Res 2009; 18: 53-65
• 21 Choi NK, Lee J, Chang Y et al. Polyethylene glycol bowel preparation does not eliminate the risk of acute renal failure: a population-based case-crossover study. Endoscopy 2013; 45: 208-213
• 22 Guo X, Nzerue C. How to prevent, recognize, and treat drug-induced nephrotoxicity. leve Clin J Med 2002; 69: 289-290 , 293–294, 296–297
• 23 Pannu N, Nadim MK. An overview of drug-induced acute kidney injury. Crit Care Med 2008; 36: 216-223
• 24 Choi NK, Chang Y, Jung SY et al. A population-based case-crossover study of polyethylene glycol use and acute renal failure risk in the elderly. World J Gastroenterol 2011; 17: 651-656
• 25 Park BJ, Sung JH, Park KD et al. Report of the evaluation for validity of discharged diagnoses in Korean Health Insurance database. Seoul: Seoul National University; 2003: 19-52
• 26 Connor A, Tolan D, Hughes S et al. Consensus guidelines for the safe prescription and administration of oral bowel-cleansing agents. Gut 2012; 61: 1525-1532
• 27 Hassan C, Bretthauer M, Kaminski MF et al. Bowel preparation for colonoscopy: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 2013; 45: 142-150